Study tests the effect of ending ambulance diversion
When a hospital's emergency department is overcrowded with seriously sick and injured patients, it may "go on diversion," re-routing ambulances to other emergency departments. But the benefits of "diversion" are largely unproven. Often those emergency departments are just as crowded, and the great...Research Finds Causal Link Between Ending Drinking, Depression
But giving mice on the wagon an antidepressant restored brain's ability to make new cells FRIDAY, July 18 (HealthDay News) -- Giving up your few drinks a day may lead to health issues, including depression, a new study says. "Our research in an animal model establishes a causal link...Brown researchers work toward ending cartilage loss
PROVIDENCE, R.I. [Brown University] Scientists have long wrestled with how to aid those who suffer cartilage damage and loss. One popular way is to inject an artificial gel that can imitate cartilage's natural ability to act as the body's shock absorber. But that solution is temporary, requiring ...MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008
LIVINGSTON, N.J., May 21 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) reported on May 20, 2008, in a Form 10-QSB filing with the Securities and Exchange Commission, net income of $2,019,862 for the quarter ending March 31, 2008, which is the third quarter of fiscal 2008...CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
Preliminary results for the year ended 31 December 2006 Product profile of lead drug candidate confirmed in large Phase III study International partnering process to commerialise M6G underway CAMBRIDGE, England, March 28, 2007 - CeNeS Pharmaceuticals plc ("CeNeS" or "the Company"), the CNS foc...Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
...mo-cvs.com . Terumo Corporation is a premier global medical device company with annual sales of more than three billion dollars for the year ending March 31, 2009. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, int...Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
...e data. This information is an estimate derived from the use of information under license from IMS National Prescription Data for the 12 month period ending December 2008. IMS expressly reserves all rights, including rights of copying, distribution and republication. ** IMS national prescription data...GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
...y, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2009. Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks at the meeting, highlighti...Bionovo Announces First Quarter 2009 Highlights and Financial Results
...ent grants, partnering, and debt and equity offerings. First Quarter Results Total operating expenses for the three months ending March 31, 2009 were $4.6 million compared to $4.2 million for the same period in 2008. Total operating expenses for the first quarter included one-ti...Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
...dex announced several other corporate changes. The Company has appointed MorisonCogen, LP of Bala Cynwyd, PA, as its independent auditors for the year ending December 31, 2008. Cordex also appointed DirectTransfer, LLC as its stock transfer agent, effective immediately. About Cordex Pharma, Inc. C...Aerospray Hematology Slide Stainer/Cytocentrifuge
Description:... The latest from the leader in automatic slide stainers. It offers a truly unique and modern approach to slide staining, ending messy procedures. The instrument of choice for peripheral blood smears, bone marrow and other body fluids. With the optional Cytopro rotor, the Aerosp...Urinary Anatomy Flash Cards (Bryan Edwards)
Features:... This PDA version clearly examines the urinary tract starting with the kidneys and ending at the blood vessels Substantial text content detailing each image, and a quiz (?) section has been added to aid as a learning tool ...Q4500 Stress Test Monitor System
Features:...t means you can start entering data immediately rather than waiting until the end of recovery to enter final report information. Enter your reason for ending the test, test impressions, and test conclusions. During this time the Q4500 continuously displays ECG waveforms in case any significant changes occur...Down Under dinosaur burrow discovery provides climate change clues
... The probable burrow etched into the Early Cretaceous outcrop is about six-feet long and one-foot in diameter. It gently descends in a semi-spiral, ending in an enlarged chamber. Martin later found two similar trace fossils in the same area. Last period of global warming The Victoria fossils a...Scientists work to plug microorganisms into the energy grid
...he problem is, unlike corn starch, the sugars necessary for fermentation are trapped inside the lignocellulose part of this plant biomass. The key to ending the food versus fuel debate is unlocking the sugars trapped in cellulosic biomass. To do that, some scientists have taken a page out of the playboo...UCSB scientists document fate of huge oil slicks from seeps at coal oil point
...ne said. "It's a good bet that it ends up in the sediments because it's not ending up on land. It's not dissolving in ocean water, so it's almost certain that it is ending up in the sediments." An all-night sampling marathon on the research shi...Weizmann Institute scientists develop a unique approach for splitting water into hydrogen and oxygen
...ter molecule. The team found that upon mixing this complex with water the bonds between the hydrogen and oxygen atoms break, with one hydrogen atom ending up binding to its organic part, while the remaining hydrogen and oxygen atoms (OH group) bind to its metal center. This modified version of the com...Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy
...The top part of the tipi resides inside the cell membrane and has two openings for substances to enter; the bottom portion sticks out inside the cell, ending in two dumbbell-shaped arms. This overall shape is strikingly similar to that of another protein, MsbA, that transports lipids out of bacteria. Th...Researchers isolate protein domain linked to tumor progression
...was important for tissue invasion events. During tissue invasion, cells from one tissue invade into and usually move through another tissue, sometimes ending up in a completely different part of the body from where the tissue was formed. This pathway is similar to metastasis, where cancer cells spread from ...Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
RESULTS REVISE AND UPDATE DONG YING Q3 RESULTS REPORTED DECEMBER 10, 2008 NANTONG CITY, China, Jan. 29 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) is pleased to report financial highlights from the complete unaudited financial results of its wholly owned operat...SPO Medical Reports Nine Month Period Ending September 2008
NEW YORK, November 20 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced its results for the nine-month period ended September 30, 2008. Despite the continued dete...Shire plc: IFRS Results for the Year Ending December 31, 2007
BASINGSTOKE, England, March 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces its preliminary results prepared under International Financial Reporting Standards ("IFRS") for the twelve months to December 31, 2007. On Feb...ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
LEUVEN, Belgium, August 24 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, today announces a business update and its financial results for the seven month period ending 30 June 2007. During this period, ThromboGenics has raised a...Governors business-plan contest has a surprise ending
MILWAUKEE Two biotechnology companies tied for the top prize at the first-annual Governors Business Plan Contest . Announced at the close of the Entrepreneurs Conference Wednesday evening in Milwaukee, Middleton-based BioSystem Development and Milwaukee-based NovaScan will split both first and se...NeurogesX Reports Second Quarter 2009 Results
... http://www.neurogesx.com . A replay of the conference call will be available beginning August 7, 2009 at 12:00 p.m. ET (9:00 a.m. PT) and ending on August 17, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 329620. A replay of ...